We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$303M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.2M
3
IYR icon
iShares US Real Estate ETF
IYR
+$17.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.4M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$26.8M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.6M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$24.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$24M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.2M

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFIN
2501
DELISTED
P&F Industries
PFIN
$6K ﹤0.01%
674
+479
+246% +$4.21K
YELL
2502
DELISTED
Yellow Corporation Common Stock
YELL
$6K ﹤0.01%
465
-2,154
-82% -$24K
CIFC
2503
DELISTED
CIFC LLC Common Shares
CIFC
$6K ﹤0.01%
604
-403
-40% -$3.6K
DEE
2504
DELISTED
DB Commodity Double Short ETN due April 1, 2038
DEE
$6K ﹤0.01%
93
– –
LDRI
2505
DELISTED
Invesco LadderRite 0-5 Year Corporate Bond ETF
LDRI
$6K ﹤0.01%
220
– –
ABUS icon
2506
Arbutus Biopharma
ABUS
$915M
$5K ﹤0.01%
1,472
-810
-35% -$3.17K
AHT
2507
Ashford Hospitality Trust
AHT
$21M
$5K ﹤0.01%
+1
New +$6.12K
AIR icon
2508
AAR Corp
AIR
$5.76B
$5K ﹤0.01%
150
-294
-66% -$7.48K
ALDX icon
2509
Aldeyra Therapeutics
ALDX
$93.5M
$5K ﹤0.01%
+579
New +$3.54K
BAX icon
2510
Baxter International
BAX
$14.2B
$5K ﹤0.01%
+100
New +$4.72K
CBAN icon
2511
Colony Bankcorp
CBAN
$467M
$5K ﹤0.01%
556
+432
+348% +$4.19K
CHCO icon
2512
City Holding Co
CHCO
$2.04B
$5K ﹤0.01%
100
-528
-84% -$25.5K
CLDX icon
2513
Celldex Therapeutics
CLDX
$3.28B
$5K ﹤0.01%
+81
New +$5.04K
CLLS
2514
Cellectis
CLLS
$285M
$5K ﹤0.01%
200
-100
-33% -$2.61K
CNOB icon
2515
Center Bancorp
CNOB
$1.78B
$5K ﹤0.01%
300
-677
-69% -$11.7K
CRDF icon
2516
Cardiff Oncology
CRDF
$77.2M
$5K ﹤0.01%
15
– –
CUK
2517
DELISTED
Carnival PLC
CUK
$5K ﹤0.01%
112
-415
-79% -$19.5K
CWBC
2518
Community West Bancshares
CWBC
$684M
$5K ﹤0.01%
284
+163
+135% +$2.47K
DMO
2519
Western Asset Mortgage Opportunity Fund
DMO
$120M
$5K ﹤0.01%
+200
New +$4.81K
DNL icon
2520
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$501M
$5K ﹤0.01%
200
-1,440
-88% -$35.3K
DNN icon
2521
Denison Mines
DNN
$2.91B
$5K ﹤0.01%
9,200
+2,700
+42% +$1.4K
DXJ icon
2522
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
$5K ﹤0.01%
+120
New +$4.99K
E icon
2523
ENI
E
$77.5B
$5K ﹤0.01%
+158
New +$4.81K
EGAN icon
2524
eGain
EGAN
$201M
$5K ﹤0.01%
1,770
+1,035
+141% +$2.92K
EMDV icon
2525
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.39M
$5K ﹤0.01%
100
– –
99 100
101
102 103

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.